The basis of current and future therapy for inflammatory bowel disease

被引:33
作者
Elson, CO [1 ]
机构
[1] UNIV ALABAMA,DIV GASTROENTEROL & HEPATOL,BIRMINGHAM,AL
关键词
D O I
10.1016/S0002-9343(96)00049-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article describes current medical therapy as well as the types and theoretical basis of novel therapies now on the horizon for treating inflammatory bowel disease.
引用
收藏
页码:656 / 662
页数:7
相关论文
共 26 条
[1]  
AZADKHAN AK, 1977, LANCET, V2, P892
[2]  
Bayless TM, 1989, CURRENT MANAGEMENT I
[3]  
CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
[4]   LONG-TERM NEOPLASIA RISK AFTER AZATHIOPRINE TREATMENT IN INFLAMMATORY BOWEL-DISEASE [J].
CONNELL, WR ;
KAMM, MA ;
DICKSON, M ;
BALKWILL, AM ;
RITCHIE, JK ;
LENNARDJONES, JE .
LANCET, 1994, 343 (8908) :1249-1252
[5]   RANDOMIZED COMPARISON OF OLSALAZINE AND MESALAZINE IN PREVENTION OF RELAPSES IN ULCERATIVE-COLITIS [J].
COURTNEY, MG ;
NUNES, DP ;
BERGIN, CF ;
ODRISCOLL, M ;
TRIMBLE, V ;
KEELING, PWN ;
WEIR, DG .
LANCET, 1992, 339 (8804) :1279-1281
[6]  
Dieleman L A, 1995, Inflamm Bowel Dis, V1, P266
[7]   RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN ;
FELDMANN, M ;
KALDEN, JR ;
ANTONI, C ;
SMOLEN, JS ;
LEEB, B ;
BREEDVELD, FC ;
MACFARLANE, JD ;
BIJL, H ;
WOODY, JN .
LANCET, 1994, 344 (8930) :1105-1110
[8]   EXPERIMENTAL-MODELS OF INFLAMMATORY BOWEL-DISEASE [J].
ELSON, CO ;
SARTOR, RB ;
TENNYSON, GS ;
RIDDELL, RH .
GASTROENTEROLOGY, 1995, 109 (04) :1344-1367
[9]  
ELSON CO, 1995, INFLAMM BOWEL DIS, P203
[10]   METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE [J].
FEAGAN, BG ;
ROCHON, J ;
FEDORAK, RN ;
IRVINE, EJ ;
WILD, G ;
SUTHERLAND, L ;
STEINHART, AH ;
GREENBERG, GR ;
GILLIES, R ;
HOPKINS, M ;
HANAUER, SB ;
MCDONALD, JWD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (05) :292-297